Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-03-20 to 2032-12-31
Current total value of award: $2961209
Description: UNILATERAL NO COST MODIFICATION TO DESIGNATE THE ALTERNATE COR DR. CAROL DIAZ-DIAZ AS THE PRIMARY COR. SAIMA ZAMAN WILL TEMPORARILY ASSUME THE ALTERNATE COR POSITION.